MERCK PATENT GMBH;CANCER RESEARCH TECHNOLOGY LIMITED
发明人:
SCHIEMANN, KAI,BLAGG, JULIAN,MALLINGER, AURELIE,RINK, CHRISTIAN,SEJBERG, JIMMY,HONEY, MARK
申请号:
CA2950238
公开号:
CA2950238A1
申请日:
2015.07.17
申请国别(地区):
CA
年份:
2016
代理人:
摘要:
The present invention relates to naphthyridine and isoquinoline compounds, and pharmaceutically acceptable compositions thereof, useful as inhibitors of CDK8/19, and for the treatment of CDK8/19-related disorders.